Optiver Holding’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $50K | Buy |
5,582
+5,073
| +997% | +$45.5K | ﹤0.01% | 349 |
|
2025
Q1 | $3.82K | Buy |
509
+460
| +939% | +$3.45K | ﹤0.01% | 878 |
|
2024
Q4 | $368 | Buy |
+49
| New | +$368 | ﹤0.01% | 687 |
|
2024
Q3 | – | Sell |
-936
| Closed | -$5.78K | – | 628 |
|
2024
Q2 | $5.78K | Buy |
+936
| New | +$5.78K | ﹤0.01% | 435 |
|